Chordate Medical Holding Stock Number Of Shares Shorted
| CMH Stock | 12.55 0.25 1.95% |
Chordate Medical Holding fundamentals help investors to digest information that contributes to Chordate Medical's financial success or failures. It also enables traders to predict the movement of Chordate Stock. The fundamental analysis module provides a way to measure Chordate Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chordate Medical stock.
Chordate |
Chordate Medical Holding Company Number Of Shares Shorted Analysis
Chordate Medical's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Chordate Medical Holding has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The number of shares shorted for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Chordate Fundamentals
| Return On Equity | -1.68 | |||
| Return On Asset | -0.71 | |||
| Operating Margin | (54.40) % | |||
| Current Valuation | 102.78 M | |||
| Shares Outstanding | 157.71 M | |||
| Shares Owned By Insiders | 39.97 % | |||
| Price To Book | 5.80 X | |||
| Price To Sales | 3,320 X | |||
| Revenue | 618.01 K | |||
| Gross Profit | 1.93 M | |||
| EBITDA | (16.85 M) | |||
| Net Income | (19.76 M) | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (17.43 M) | |||
| Earnings Per Share | (0.18) X | |||
| Beta | 1.27 | |||
| Market Capitalization | 80.99 M | |||
| Total Asset | 31.22 M | |||
| Net Asset | 31.22 M |
About Chordate Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chordate Medical Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chordate Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chordate Medical Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.